Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Froehner
Fischer
Wirth

Cancer

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer|November 1, 1986
A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinomaT P Mate, D Carter, D B Fischer, et al.
Cancer|February 8, 2007
Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and ImatinibFlorian Heidel, Jorge Cortes, Frank G Rücker, et al.
Cancer|August 30, 2000
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinomaM Retz, J Lehmann, C Trocha, et al.
Cancer|November 1, 1993
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2bY Z Patt, B Yoffe, C Charnsangavej, et al.
Cancer|May 12, 1998
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashesS K Quella, C L Loprinzi, J A Sloan, et al.
Cancer|December 11, 1999
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanomaW J Poo-Hwu, S Ariyan, L Lamb, et al.
Cancer|November 20, 2009
Expression of interleukin 15 in primary adult acute lymphoblastic leukemiaShuling Wu, Lars Fischer, Nicola Gökbuget, et al.
Cancer|December 29, 2015
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group projectDaria Thompson, Kieuhoa T Vo, Wendy B London, et al.
Cancer|May 13, 2016
Refinement and revalidation of the demoralization scale: The DS-II-external validitySophie Robinson, David W Kissane, Joanne Brooker, et al.
Cancer|November 19, 2016
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer DatabaseBenjamin W Fischer-Valuck, Ishita Chen, Amar J Srivastava, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer|November 1, 1986
A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinomaT P Mate, D Carter, D B Fischer, et al.
Cancer|February 8, 2007
Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and ImatinibFlorian Heidel, Jorge Cortes, Frank G Rücker, et al.
Cancer|August 30, 2000
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinomaM Retz, J Lehmann, C Trocha, et al.
Cancer|November 1, 1993
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2bY Z Patt, B Yoffe, C Charnsangavej, et al.
Cancer|May 12, 1998
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashesS K Quella, C L Loprinzi, J A Sloan, et al.
Cancer|December 11, 1999
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanomaW J Poo-Hwu, S Ariyan, L Lamb, et al.
Cancer|November 20, 2009
Expression of interleukin 15 in primary adult acute lymphoblastic leukemiaShuling Wu, Lars Fischer, Nicola Gökbuget, et al.
Cancer|December 29, 2015
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group projectDaria Thompson, Kieuhoa T Vo, Wendy B London, et al.
Cancer|May 13, 2016
Refinement and revalidation of the demoralization scale: The DS-II-external validitySophie Robinson, David W Kissane, Joanne Brooker, et al.
Cancer|November 19, 2016
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer DatabaseBenjamin W Fischer-Valuck, Ishita Chen, Amar J Srivastava, et al.
Pageof 9